Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
Michele Carron, Fabio Baratto, Francesco Zarantonello, Carlo Ori Department of Medicine, Anesthesiology and Intensive Care, University of Padova, Padova, Italy Objective: The aim of the study is to evaluate the clinical and economic impact of introducing a rocuronium–neostigmine–...
Saved in:
Main Authors: | Carron M (Author), Baratto F (Author), Zarantonello F (Author), Ori C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
by: Sang‐Hwan Ji, et al.
Published: (2023) -
Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
by: Sang-Hwan Ji, et al.
Published: (2023) -
Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
by: Evangelia Samara, et al.
Published: (2020) -
Sugammadex to reverse residual neuromuscular blockade and facilitate neurologic examination in an adolescent trauma patient in the Pediatric ICU setting.
by: T. Renner, et al.
Published: (2023) -
Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis
by: Bingchen Lang, et al.
Published: (2022)